Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 5, 2005, Pages 685-688

  Jahnz Rozyk, K ^a   Targowski, T ^a   Paluchowska, E ^a   Owczarek, W ^a   Kucharczyk, A ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Atopic dermatitis; Macrophage derived chemokine; Thymus and activation regulated chemokine

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; EOTAXIN; IMMUNOGLOBULIN E; MACROPHAGE DERIVED CHEMOKINE; THYMULIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORAD SCORE; SCORING SYSTEM; SKIN DEFECT; STATISTICAL SIGNIFICANCE; TH2 CELL; THYMUS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINES, CC; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; OSMOLAR CONCENTRATION; SEVERITY OF ILLNESS INDEX;

EID: 17644383278     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00774.x     Document Type: Article

References (23)

1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stock) 1980;92(Suppl.):44-47.
2. Leung DYM. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997;107(Suppl.):25-30.
3. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994;94:870-876.
4. Sekiya T, Yamada H, Yamaguchi M, Yamamoto K, Ishii A, Yoshie O et al. Increased levels of a Th2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 2002;57:173-177.
5. Furukawa H, Nakamura K, Zheng X, Tojo M, Oyama N, Akiba H et al. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis. J Dermatol Sci 2004;35:35-42.
6. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002;127:270-273.
7. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takchara M, Sat S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001;293:350-355.
8. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H et al. Presence of high contents of thymus activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002;110:139-146.
9. Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Nakamura K et al. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 2003;134:309-313.
10. Morita A, Shimosako K, Kikuoka S, Taniguchi Y, Kitaura M, Sasakura K et al. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood. J Immunol Methods 1999;226:159-167.
11. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea-pig lung. J Exp Med 1995;181:1211-1216.
12. Fukuyama S, Inoue H, Aizawa H, Oike M, Kitaura M, Yoshie O et al. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. Am J Respir Crit Care Med 2000;161:1844-1849.
13. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-19.
14. Wuthirch B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated (extrinsic) and the nonallergic (intrisic) AEDS. J Investig Allergol Clin Immunol 2003;13:1-5.
15. Greiff L, Peterson H, Mattsson E, Andersson M, Erjefalt JS, Linden M et al. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment. Clin Exp Allergy 2001;31:1321-1327.
16. Katoh S, Fukushima K, Matsumoto N, Matsumoto K, Abe K, Onai N et al. Accumulation of CCR-4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2003;58:518-523.
17. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez A, Coyle AJ et al. CC choking receptor (CCR) 3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T-helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000;191:265-274.
18. Kawasaki S, Takizawa H, Yoneyama H, Nakayama T, Fujisawa R, Izumizaki M et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. I Immunol 2001;166:2055-2062.
19. Morita E, Hiragun T, Mihara S, Kaneko S, Matsuo H, Zhang Y et al. Determination of thymus and activation-regulated chemokine (TARC) - contents in scales of atopic dermatitis. J Dermatol Sci 2004;34:237-240.
20. Lezcano-Meza D, Negrete-Garcia MC, Dante-Escobedo M, Teran LM. The monocyte-derived chemokine is released in the bronchoalveolar lavage fluid of steady-state asthmatics. Allergy 2003;58:1125-1130.
21. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169-1174.
22. Lilly CM, Woodruff PG, Camargo CA, Nakamura H, Drazen JM, Nadel ES et al. Elevated plasma eotaxin levels in patients with acute asthma. J Allergy Clin Immunol 1999;104:786-790.
23. Hossny E, Aboul-Magd M, Bakr S. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 2001;56:996-1002.